Nuveen Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $15.7M | Buy |
795,612
+54,361
| +7% | +$1.08M | ﹤0.01% | 1317 |
|
2024
Q3 | $18.5M | Sell |
741,251
-25,160
| -3% | -$629K | 0.01% | 1246 |
|
2024
Q2 | $14.3M | Sell |
766,411
-64,688
| -8% | -$1.21M | ﹤0.01% | 1350 |
|
2024
Q1 | $16.4M | Buy |
831,099
+420,075
| +102% | +$8.29M | ﹤0.01% | 1302 |
|
2023
Q4 | $7.21M | Sell |
411,024
-152,902
| -27% | -$2.68M | ﹤0.01% | 1776 |
|
2023
Q3 | $9.8M | Buy |
563,926
+450,181
| +396% | +$7.82M | ﹤0.01% | 1498 |
|
2023
Q2 | $1.6M | Hold |
113,745
| – | – | ﹤0.01% | 2447 |
|
2023
Q1 | $1.22M | Sell |
113,745
-40,573
| -26% | -$437K | ﹤0.01% | 2536 |
|
2022
Q4 | $2.31M | Buy |
154,318
+50,931
| +49% | +$763K | ﹤0.01% | 2321 |
|
2022
Q3 | $1.33M | Sell |
103,387
-4,767
| -4% | -$61.2K | ﹤0.01% | 2608 |
|
2022
Q2 | $1.05M | Buy |
108,154
+14,176
| +15% | +$137K | ﹤0.01% | 2757 |
|
2022
Q1 | $966K | Sell |
93,978
-13,331
| -12% | -$137K | ﹤0.01% | 2826 |
|
2021
Q4 | $1.26M | Buy |
107,309
+4,493
| +4% | +$52.9K | ﹤0.01% | 2771 |
|
2021
Q3 | $1.25M | Sell |
102,816
-670
| -0.6% | -$8.17K | ﹤0.01% | 2899 |
|
2021
Q2 | $1.44M | Buy |
103,486
+11,543
| +13% | +$161K | ﹤0.01% | 2858 |
|
2021
Q1 | $1.7M | Sell |
91,943
-337,060
| -79% | -$6.24M | ﹤0.01% | 2691 |
|
2020
Q4 | $7.58M | Sell |
429,003
-15,626
| -4% | -$276K | ﹤0.01% | 1870 |
|
2020
Q3 | $6.81M | Buy |
444,629
+115,527
| +35% | +$1.77M | ﹤0.01% | 1751 |
|
2020
Q2 | $8.39M | Buy |
329,102
+62,915
| +24% | +$1.6M | ﹤0.01% | 1602 |
|
2020
Q1 | $4.12M | Buy |
266,187
+229,217
| +620% | +$3.55M | ﹤0.01% | 1828 |
|
2019
Q4 | $409K | Sell |
36,970
-3,770
| -9% | -$41.7K | ﹤0.01% | 2949 |
|
2019
Q3 | $347K | Buy |
40,740
+2,251
| +6% | +$19.2K | ﹤0.01% | 3029 |
|
2019
Q2 | $521K | Buy |
+38,489
| New | +$521K | ﹤0.01% | 2985 |
|